The Leeds Teaching Hospitals NHS Trust

Research and Innovation

Experimental Cancer Medicine Centres

The ECMCs vision is to bring together laboratory and clinical patient-based research to speed up the development of new therapies and individualise patient treatment. The ECMCs aim to:

  • Enhance the delivery of early phase trials by increasing capacity, safety and speed, to improve the success rates in developing therapeutic modalities for patient benefit.
  • Maximise therapeutic opportunities for patients by developing biomarkers, and molecular phenotyping patient samples, to identify sub-populations that differ in their susceptibility to cancer or response to treatment.
  • Ensure that the UK remains at the forefront of international efforts to develop and test new treatments for cancer, built upon outstanding science and optimal trial design.
  • Increase the attractiveness of the UK as a location for industry-sponsored/funded and collaborative experimental cancer medicine.
  • Ensure effective joint working across the network and between Universities and Trusts.
  • Promote patient and public involvement in experimental cancer medicine.

To read the full report please follow the link to the Experimental Cancer Medicine Centre .pdf

Full details are also available